HERCULES, CA--(Marketwired - Aug 3, 2015) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B), today announced the launch of the IH-500, a fully automated random access system for blood typing and ...
HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received 510 ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and the South African National Blood Service (SANBS) have announced that they have substantially completed the rollout of Bio-Rad’s IH-500 ...
HERCULES, CA--(Marketwired - Oct 24, 2016) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, today announced that ...
HERCULES, CA--(Marketwired - May 24, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIOb), a global provider of life science research and clinical diagnostic products, today announced that it ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received ...
Bio-Rad Laboratories Inc. (NYSE: BIO) recently received 510 (k) clearance from the FDA for its automated random-access system for blood typing and screening — IH-500. Bio-Rad is a global pioneer in ...